Search Results - "Hanenberg, H"

Refine Results
  1. 1

    Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair by Park, J-Y, Singh, T R, Nassar, N, Zhang, F, Freund, M, Hanenberg, H, Meetei, A R, Andreassen, P R

    Published in Oncogene (02-10-2014)
    “…Heterozygous carriers of germ-line mutations in the BRCA2/FANCD1 , PALB2/FANCN and RAD51C/FANCO DNA repair genes have an increased lifetime risk of developing…”
    Get full text
    Journal Article
  2. 2

    Evidence for a novel anti-apoptotic pathway in human keratinocytes involving the aryl hydrocarbon receptor, E2F1, and checkpoint kinase 1 by Frauenstein, K, Sydlik, U, Tigges, J, Majora, M, Wiek, C, Hanenberg, H, Abel, J, Esser, C, Fritsche, E, Krutmann, J, Haarmann-Stemmann, T

    Published in Cell death and differentiation (01-10-2013)
    “…Exposure of keratinocytes (KC) to ultraviolet (UV) radiation results in the initiation of apoptosis, a protective mechanism that eliminates cells harboring…”
    Get full text
    Journal Article
  3. 3

    Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells in vitro and in vivo by Bister, A., Ibach, T., Haist, C., Gerhorst, G., Smorra, D., Soldierer, M., Roellecke, K., Wagenmann, M., Scheckenbach, K., Gattermann, N., Wiek, C., Hanenberg, H.

    Published in Molecular therapy. Oncolytics (15-09-2022)
    “…Chimeric antigen receptor (CAR) T cell therapy has demonstrated unprecedented success with high remission rates for heavily pretreated patients with…”
    Get full text
    Journal Article
  4. 4

    Optimized human CYP4B1 in combination with the alkylator prodrug 4-ipomeanol serves as a novel suicide gene system for adoptive T-cell therapies by Roellecke, K, Virts, E L, Einholz, R, Edson, K Z, Altvater, B, Rossig, C, von Laer, D, Scheckenbach, K, Wagenmann, M, Reinhardt, D, Kramm, C M, Rettie, A E, Wiek, C, Hanenberg, H

    Published in Gene therapy (01-07-2016)
    “…Engineering autologous or allogeneic T cells to express a suicide gene can control potential toxicity in adoptive T-cell therapies. We recently reported the…”
    Get full text
    Journal Article
  5. 5

    Squamous cell carcinomas of the head and neck in Fanconi anemia: risk, prevention, therapy, and the need for guidelines by Scheckenbach, K, Wagenmann, M, Freund, M, Schipper, J, Hanenberg, H

    Published in Klinische Padiatrie (01-04-2012)
    “…Fanconi anemia (FA) is a rare recessive DNA repair disorder that is clinically characterized by congenital malformations, progressive bone marrow failure, and…”
    Get more information
    Journal Article
  6. 6
  7. 7

    The centrosomal protein TACC3 controls paclitaxel sensitivity by modulating a premature senescence program by Schmidt, S, Schneider, L, Essmann, F, Cirstea, I C, Kuck, F, Kletke, A, Jänicke, R U, Wiek, C, Hanenberg, H, Ahmadian, M R, Schulze-Osthoff, K, Nürnberg, B, Piekorz, R P

    Published in Oncogene (18-11-2010)
    “…Microtubule-interfering cancer drugs such as paclitaxel (PTX) often cause chemoresistance and severe side effects, including neurotoxicity. To explore…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Outcomes of mismatched and unrelated donor hematopoietic stem cell transplantation in Fanconi anemia conditioned with chemotherapy only by Chao, M. M., Kuehl, J. S., Strauss, G., Hanenberg, H., Schindler, D., Neitzel, H., Niemeyer, C., Baumann, I., von Bernuth, H., Rascon, J., Nagy, M., Zimmermann, M., Kratz, C. P., Ebell, W.

    Published in Annals of hematology (01-08-2015)
    “…Fanconi anemia (FA) is a genomic instability syndrome associated with bone marrow failure, myelodysplastic syndrome (MDS), and/or acute myeloid leukemia (AML)…”
    Get full text
    Journal Article
  10. 10

    Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer by Mantere, T., Haanpää, M., Hanenberg, H., Schleutker, J., Kallioniemi, A., Kähkönen, M., Parto, K., Avela, K., Aittomäki, K., von Koskull, H., Hartikainen, J.M., Kosma, V.-M., Laasanen, S.-L., Mannermaa, A., Pylkäs, K., Winqvist, R.

    Published in Clinical genetics (01-07-2015)
    “…Mutations in downstream Fanconi anemia (FA) pathway genes, BRCA2, PALB2, BRIP1 and RAD51C, explain part of the hereditary breast cancer susceptibility, but the…”
    Get full text
    Journal Article
  11. 11

    Consensus of German transplant centers on hematopoietic stem cell transplantation in Fanconi anemia by Chao, M M, Ebell, W, Bader, P, Beier, R, Burkhardt, B, Feuchtinger, T, Handgretinger, R, Hanenberg, H, Koehl, U, Kratz, C, Kremens, B, Lang, P, Meisel, R, Mueller, I, Roessig, C, Sauer, M, Schlegel, P G, Schulz, A, Strahm, B, Thol, F, Sykora, K W

    Published in Klinische Padiatrie (01-05-2015)
    “…Allogeneic hematopoietic stem cell transplantation (HSCT) is currently the only curative therapy for the severe hematopoietic complications associated with…”
    Get more information
    Journal Article
  12. 12

    Targeted expression of human folylpolyglutamate synthase for selective enhancement of methotrexate chemotherapy in osteosarcoma cells by Bienemann, K, Staege, M S, Howe, S J, Sena-Esteves, M, Hanenberg, H, Kramm, C M

    Published in Cancer gene therapy (01-09-2013)
    “…The antifolate methotrexate (MTX) is an important chemotherapeutic agent for treatment of osteosarcoma. This drug is converted intracellularly into…”
    Get full text
    Journal Article
  13. 13

    Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction by Gross, M, Hanenberg, H, Lobitz, S, Friedl, R, Herterich, S, Dietrich, R, Gruhn, B, Schindler, D, Hoehn, H

    Published in Cytogenetic and genome research (01-01-2002)
    “…Fanconi anemia (FA) is a genetically and phenotypically heterogenous autosomal recessive disease associated with chromosomal instability and hypersensitivity…”
    Get more information
    Journal Article
  14. 14

    Significantly increased CD70 up regulation on TEL-AML positive B cell precursor acute lymphoblastic leukemia cells following CD40 stimulation by Troeger, A, Glouchkova, L, Ackermann, B, Escherich, G, Hanenberg, H, Janka, G, Roettgers, S, Göbel, U, Dilloo, D

    Published in Klinische Padiatrie (01-11-2014)
    “…TEL-AML the most common genetic alteration in childhood precursor B acute lymphoblastic leukemia (BCP-ALL) is associated with a favorable prognosis. We studied…”
    Get more information
    Journal Article
  15. 15

    Empowering nurses and midwives: the evidence-base for the Nurses and Midwives Certification Programme of ESHRE by Somers, S, Cotton, H, Kendrew, H, Pomper, J, Pinborg, A, Jorgensen, I R, Plas, C, Hanenberg, E H, Peddie, V L, Dancet, E A F

    Published in Human reproduction (Oxford) (28-08-2024)
    “…Abstract STUDY QUESTION How were the logbook and curriculum for the Nurses and Midwives Certification Programme of ESHRE developed? SUMMARY ANSWER The logbook…”
    Get full text
    Journal Article
  16. 16

    Disruption of the FA/BRCA pathway in bladder cancer by Neveling, K, Kalb, R, Florl, A R, Herterich, S, Friedl, R, Hoehn, H, Hader, C, Hartmann, F H, Nanda, I, Steinlein, C, Schmid, M, Tonnies, H, Hurst, C D, Knowles, M A, Hanenberg, H, Schulz, W A, Schindler, D

    Published in Cytogenetic and genome research (01-01-2007)
    “…Bladder carcinomas frequently show extensive deletions of chromosomes 9p and/or 9q, potentially including the loci of the Fanconi anemia (FA) genes FANCC and…”
    Get more information
    Journal Article
  17. 17

    Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis by SCHULZE, K. M. M, HANEMANN, C. O, MÜLLER, H. W, HANENBERG, H

    Published in Human molecular genetics (2002)
    “…Mutations in both alleles of the tumour suppressor gene coding for merlin/schwannomin, an ERM family protein, cause the hereditary disease neurofibromatosis…”
    Get full text
    Journal Article
  18. 18

    TACC3 depletion sensitizes to paclitaxel-induced cell death and overrides p21WAF-mediated cell cycle arrest by Schneider, L, Essmann, F, Kletke, A, Rio, P, Hanenberg, H, Schulze-Osthoff, K, Nürnberg, B, Piekorz, R P

    Published in Oncogene (03-01-2008)
    “…Regulators of the mitotic spindle apparatus are attractive cellular targets for antitumor therapy. The centrosomal protein transforming acidic coiled coil…”
    Get full text
    Journal Article
  19. 19

    A simplified approach to improve the efficiency and safety of ex vivo hematopoietic gene therapy in fanconi anemia patients by Jacome, A, Navarro, S, Casado, J A, Rio, P, Madero, L, Estella, J, Sevilla, J, Badell, I, Ortega, J J, Olivé, T, Hanenberg, H, Segovia, J C, Bueren, J A

    Published in Human gene therapy (01-02-2006)
    “…Fanconi anemia (FA) is an inherited DNA repair disorder characterized by genetic instability of cells lacking a functional FA/BRCA pathway. Previous studies…”
    Get more information
    Journal Article
  20. 20

    Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library by Li, Z., Stanelle, J., Leurs, C., Hanenberg, H., Pützer, B. M.

    Published in Nucleic acids research (01-01-2005)
    “…The E2F1 transcription factor is an essential mediator of p53-dependent and p53-independent apoptosis as part of an anti-tumour safeguard mechanism. In this…”
    Get full text
    Journal Article